Breast Cancer Early Stage Breast Cancer (Stage 1-3) Clinical Trials
2 recruiting trials for Breast Cancer Early Stage Breast Cancer (Stage 1-3). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Breast Cancer Early Stage Breast Cancer (Stage 1-3) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University College London Hospitals (1), University of Illinois at Chicago (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is ScarWork therapy (other, 1 trial), followed by Time restricted eating.
Track Breast Cancer Early Stage Breast Cancer (Stage 1-3) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome.
Breast cancer is the most common cancer in women in the United Kingdom (UK). Most women are treated with a combination of surgery and radiotherapy. While these treatments are...
Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.
This study is being done to better understand how time restricted eating (eating all food in an 8 hour window) can help a person receiving chemotherapy treatment for breast...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Breast Cancer Early Stage Breast Cancer (Stage 1-3), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Breast Cancer Early Stage Breast Cancer (Stage 1-3), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Breast Cancer Early Stage Breast Cancer (Stage 1-3), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.